NASDAQ:BIOL   Biolase, Inc
Idea only not professional advice

BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers.
2021 First Quarter Operating Highlights (all comparisons are on a year over year basis):

Net revenue grew 70% to $8.1 million with:

Laser system sales increased 139%

Consumables and other revenue increased 52%

U.S. revenue increased 67%

International revenue increased 75%

The gross margin was 34%, up 500 basis points

Maintained a strong balance sheet , as cash and cash equivalents totaled $40.8 million on March 31, 2021, up from $17.6 million on December 31, 2020.

Good reports combined with volume entry, the direction seems to be up